Galmed Pharmaceuticals Ltd. Stock Prediction
AI-powered sentiment analysis and prediction trends for GLMD, updated each market day.
GLMD AI Sentiment
AI predicts Galmed Pharmaceuticals Ltd. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
Exchange
Market Cap
$5,182,048
Cap Tier
Employees
6
Listed Since
March 13, 2014
Website
GLMD Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
GLMD Volatility
Galmed Pharmaceuticals Ltd. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
